His son being accepted for campus housing is welcome news, writes columnist Joe MacDonald, who must now focus on learning to ...

In a real-world study in South Korea, approved hemophilia A therapy Adynovate zeroed out the number of bleeding episodes for ...

Saying “I’m here if you need to talk” is a testament to my son’s strength. It sounds like a simple phrase that most would use, but it’s more than that for Caeleb. It’s evidence that he uses his life ...

Columnist Allyx Formalejo's neurodivergence and her husband's hemophilia have helped, not hurt, in finding purpose in their ...

Switching to the extended half-life therapy Elocta, sold in the U.S. as Eloctate, improved control of bleeds among hemophilia ...

Since earning her ham radio license, columnist G Shellye Horowitz is grateful to have a reliable source of connection and communication.

The Rare Rewritten campaign hopes to change a misconception about women with X-linked disorders, columnist G Shellye Horowitz ...

Alhemo’s expanded approval drew on explorer8, a Phase 3 study that enrolled about 150 hemophilia A or B patients, who didn't ...

Columnist Allyx Formalejo says that due to ADHD, her tendency to be hyperfocused and need to "help" is really a need for ...

With the launch of a U.S. trial, a treatment using the B-cell medicine BE-101 has been given to a hemophilia B patient for ...

As someone with von Willebrand disease, columnist Jennifer Lynne hopes that trials for VGA039 could lead to a long-sought new treatment.

Columnist Joe MacDonald, who has essential tremors, shares with his sons the feeling of having a sometimes visible disorder.